Barclays Maintains Overweight on Elanco Animal Health, Raises Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad has maintained an Overweight rating on Elanco Animal Health (ELAN) and increased the price target from $19 to $23.
May 09, 2024 | 3:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays has maintained an Overweight rating on Elanco Animal Health and raised the price target from $19 to $23.
The upgrade in the price target by Barclays, a major financial institution, reflects a positive outlook on Elanco Animal Health's future performance. This is likely to be viewed favorably by investors, potentially leading to an increase in the stock's price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100